September 18, 2014
by Alexander Gaffney, RAC

Introducing Some New Voices (and Changes) Here at Regulatory Focus

If you've been keeping close track of Regulatory Focus over the last few months, you've probably already noticed some new names in article bylines. Focus has been teaming up with several trusted content providers to offer you unparalleled access to breaking news, unique data-based insights and regulatory events.

In addition to RegLink, which has long provided us with hard-to-find information on global regulatory developments, we're pleased to now offer news from:

  • Tarius, whose SAC Tracker service is providing Focus with exclusive access to their FDA scientific advisory committee tracking services. Check out their calendar page for sneak previews of upcoming FDA advisory committee events, as well as analysis of all past meetings and events.
  • Graematter, a provider of regulatory intelligence services, is now giving Focus readers extraordinary looks at FDA data and explanations of how trends can impact the medical device industry—and you.
  • Emergo Group, a provider of medical device information, giving Focus readersupdates and insight on global device news and regulation.

All of this information will be freely available to all readers of Focus, and we will be adding more voices to our roster of high-quality contributors in the coming months as well.

In recent days we have also introduced a new news feature we are calling RegBits. Written with busy regulatory professionals in mind, RegBits provides an at-a-glance overview of the day's top regulatory news and events. We hope this will be especially valuable for those of you who cover multiple product areas.

Unique Insights for RAPS Members

For those looking for even more information and insight, we have good news. Focus has teamed up with two trusted providers of regulatory information to offer RAPS members exclusive access to regulatory insight and analysis difficult to find anywhere else.

Both Taylor's and Brown-Tuttle's work will be available exclusively to RAPS members. If you're not a RAPS member, you can join (and thereby obtain access to Focus) here.

We hope that you've already been enjoying and benefiting from our new content, but if you have any recommendations, feedback or ideas, please send us your thoughts at [email protected].

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.